Category: Regulation & Policy
Regulation & Policy market research reports by FirstWord
-
Meeting the Scientific Communication Needs of Multiple Stakeholders
Meeting the Scientific Communication Needs of Multiple Stakeholders How can medical affairs meet the diverse scientific information needs of multiple stakeholders? The timely delivery of trusted, current and relevant scientific data to key stakeholder groups is an increasingly critical medical affai ... Read More
-
Orphan Drugs: New thinking on RWE generation and value
Orphan Drugs: New thinking on RWE generation and value From clinical trial planning and better education of HCPs to meeting the demands of diverse stakeholder groups, real-world evidence (RWE) is increasingly playing a pivotal role in the successful development and launch of an orphan drug. But how ... Read More
-
Orphan Drugs: Pharma/DTC genetic testing partnerships
Orphan Drugs: Pharma/DTC genetic testing partnerships The rapidly developing field of direct-to-consumer (DTC) genetic testing offers orphan drug developers the opportunity to directly support patients and HCPs while unlocking new insights in rare diseases that can inform clinical development progra ... Read More
-
The Rise of Patient Support Programs: Opportunities for Pharma
The Rise of Patient Support Programs: Opportunities for Pharma Advanced, well-designed patient support programs (PSP) are central to pharma’s patient centricity agenda and can deliver multiple stakeholder and commercial benefits. But challenges remain. How can you build awareness of your PSP? In wh ... Read More